Comparative analysis of the causes of insolvency of large companies in Russia and abroad
Economic Analysis Theory and Practice · 26.02.2026 · 37
DOI: 10.24891/tapagu ↗Kurz gefasst
Fachartikel in der Zeitschrift Economic Analysis Theory and Practice, online erschienen am 26.02.2026. Verfasst von Mariya A. NIKONOVA und 1 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Subject. The reasons that led large companies to insolvency.
Objectives
To identify the factors that led large companies to insolvency.
Methods
For the study, we used descriptive, comparative, analytical, and comparative methods.
Results
The main reasons that led large foreign and Russian companies to insolvency are shown. It has been established that the company's use of a deliberately false development strategy, despite the fact that it contributes to its fictitious growth to the level of a large company, ultimately leads to its insolvency. The factors that led large companies to a negative result of their activities, namely, insolvency, have been identified.
Conclusions
Despite all the differences, the reasons for the insolvency of large companies are the same both in Russia and abroad. A special feature for Russian large companies is their dependence on the external and internal political and economic situation.
Zitieren
APA
NIKONOVA, M. A., & AKINFEEVA, E. V. (2026). Comparative analysis of the causes of insolvency of large companies in Russia and abroad. Economic Analysis Theory and Practice, 37. https://doi.org/10.24891/tapagu
Vancouver
NIKONOVA MA, AKINFEEVA EV. Comparative analysis of the causes of insolvency of large companies in Russia and abroad. Economic Analysis Theory and Practice. 2026:37. doi:10.24891/tapagu
BibTeX
@article{NIKONOVA2026,
author = {NIKONOVA, Mariya A. and AKINFEEVA, Ekaterina V.},
title = {Comparative analysis of the causes of insolvency of large companies in Russia and abroad},
journal = {Economic Analysis Theory and Practice},
year = {2026},
pages = {37},
doi = {10.24891/tapagu}
}
EUVIMED